Business Acquisition, Fixed Exchange Ratio

No definition available.

Name:	asrt_BusinessAcquisitionFixedExchangeRatio
Namespace Prefix:	asrt_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Business Combination, Potential Premium

+ References

No definition available.

+ Details

Name:	asrt_BusinessCombinationPotentialPremium
Namespace Prefix:	asrt_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionSharePrice
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477

+ Details

Name:	us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.

+ References

No definition available.

+ Details

Name:	us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

The parent entity's interest in net assets of the subsidiary, expressed as a percentage.

+ References

No definition available.

+ Details

Name:	us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	dei_LegalEntityAxis=asrt_RolvedonMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=asrt_SpectrumPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=asrt_AssertioStockholdersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ConsolidatedEntitiesAxis=asrt_AssertioMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=asrt_SpectrumStockholdersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_OwnershipAxis=asrt_SpectrumPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

SUBSEQUENT EVENTS (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
	Apr. 25, 2023	Dec. 31, 2025	Dec. 31, 2024
Rolvedon \| Forecast
Subsequent Event [Line Items]
Proceeds from sale of equity		$ 225,000	$ 175,000
Spectrum Pharmaceuticals, Inc. \| Rolvedon \| Forecast
Subsequent Event [Line Items]
Business acquisition, share price (in dollars per share)			$ 0.10
Subsequent Event \| Spectrum Pharmaceuticals, Inc. \| Assertio Stockholders \| Assertio
Subsequent Event [Line Items]
Business acquisition, fixed exchange ratio	$ 0.1783
Purchase price	$ 248,000
Business acquisition, share price (in dollars per share)	$ 1.14
Subsequent Event \| Spectrum Pharmaceuticals, Inc. \| Spectrum Stockholders
Subsequent Event [Line Items]
Purchase price	$ 43,000
Business acquisition, share price (in dollars per share)	$ 0.20
Business combination, potential premium	94.00%
Subsequent Event \| Spectrum Pharmaceuticals, Inc. \| Spectrum Stockholders \| Assertio
Subsequent Event [Line Items]
Purchase price	$ 291,000
Business acquisition, share price (in dollars per share)	$ 1.34
Subsequent Event \| Spectrum Pharmaceuticals, Inc. \| Rolvedon
Subsequent Event [Line Items]
Business acquisition, share price (in dollars per share)	$ 0.10
Subsequent Event \| Spectrum Pharmaceuticals, Inc.
Subsequent Event [Line Items]
Noncontrolling interest, ownership percentage by parent	65.00%
Noncontrolling interest, ownership percentage by noncontrolling owners	35.00%
Subsequent Event \| Spectrum Pharmaceuticals, Inc. \| Spectrum Pharmaceuticals, Inc.
Subsequent Event [Line Items]
Noncontrolling interest, ownership percentage by parent	65.00%